PropertyValue
?:abstract
  • Tocilizumab, an IL-6 receptor antagonist, has been used to treat critically ill patients with Coronavirus Disease-2019 (COVID-19). We present the case of a previously immunocompetent man with COVID-19 who developed invasive pulmonary aspergillosis after treatment with tocilizumab, illustrating the importance of considering opportunistic infections when providing immune modulating therapy.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1016/j.diagmicrobio.2020.115272
?:journal
  • Diagn_Microbiol_Infect_Dis
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/df3bddc3ac45906533cb160add2f9668cbf90a89.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7677089.xml.json
?:pmcid
?:pmid
?:pmid
  • 33388572.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Invasive Pulmonary Aspergillosis After Treatment with Tocilizumab in a Patient with COVID-19 ARDS: A Case Report
?:type
?:year
  • 2020-11-20

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/l6ba8tz6>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/l6ba8tz6>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all